An Outstanding Preview Screening of our ME Documentary Film

Japan ME Association hosted its first preview screening of “Hope to these Hands: The Reality of ME/CFS,” our original documentary film depicting the situation of severely ill ME/CFS patients in Japan which we began filming in 2014, at the TKP Shinagawa Conference Center in Shinagawa, Tokyo on October 22, 2017. Despite rain from a typhoon, many people turned out for the event and we were able to hold a highly successful premiere of the film. We extend our heartfelt gratitude to everyone who attended, as well as to those who worked tirelessly to raise funds to make production of the film possible.

With JMEA board member Dr. Isu Shin, MD moderating, JMEA President Mieko Shinohara  thanked Director Seiji Arihara for making the film and expressed that the objective of making and screening the film before audiences in Japan was to raise accurate awareness about ME and to advance research for the disease.

Mr. Arihara then gave a candid introduction to the film, revealing that when he and Ms. Shinohara  first produced a Japanese-subtitled version of the American documentary film “I Remember Me,” many years ago, he had never imagined that he would one day be making a Japanese documentary about Japanese ME patients. He explained that it was a film that required acquiring a deep understanding of the disease, and expressed his apologies to the many patients who agreed to be filmed but who were not depicted in the final version of the documentary.

The film depicts the lives of patients who are severely affected by this neuroimmune disease, the activities of the patient association amidst a society that does not recognize or understand the illness, the consequences of patients’ inability to obtain Disability Certificates with an ME/CFS diagnosis, the personal and economic difficulties faced by patients, recent research developments in Japan and abroad, and finally the hope surrounding the recent research into effective treatments.

We received immediate feedback on the film after the screening. Comments included: “Thank you for making this film,” “The film captured patients’ thoughts and troubles concisely,” “It was encouraging to learn about all the research being done in the United States,” “I was happy that the film makes clear that ‘stress’ is not the cause of the illness,” “I felt encouraged to overcome the difficulties that I experience,” “The film achieved a balance between subjective patient experiences and objective information,”  and “I want the severely ill patients who couldn’t make it to the screening to see the film as soon as possible.”

After a short break, former JMEA Vice President Dr. Miwako Hosoda spoke about the remarkable journey of Japan ME Association’s efforts in engaging medical researchers, government policymakers, social scientists, other non-profit associations, and the media to improve the situation of patients’ lives.

Finally, Dr. Takashi Yamamura, Director of Immunology at the National Center of Neurology and Psychiatry (NCNP) gave a presentation entitled “Directions in ME/CFS Research.” Dr. Yamamura, a specialist in multiple sclerosis (MS) who is now also engaged in ME/CFS research, gave the example of developments in MS, where after 25 years of having no effective treatments, there are now around five drug treatments for the disease, with many patients able to work; when one drug emerges, the landscape can change dramatically within 10 years. Neurological diseases often are not detected by standard medical tests, as is the case with ME/CFS. He opined on the importance of research on inflammation in the brain and about the potential for major research advances in Japan; Japan should not merely depend on research to come out of the United States, especially with the high level of Japan’s immunological research, with its research institutions possessing the same technology as research universities like Stanford University. Dr. Yamamura emphasized the importance of detecting the disease early in patients going forward, and the possibility of using existing drugs to treat the disease. 

Finally, we held a press conference.  We answered questions including how we planned to use the documentary to spread awareness in Japan, whether the name “chronic fatigue syndrome” would change, and what steps were necessary to obtain the necessary funding to advance medical research.